DOI: https://doi.org/10.14710/jbtr.v6i3.9088

SRY-negative in 46, XX Male Testicular DSD: a case report

Faculty of Medicine, Diponegoro University, Indonesia

Received: 4 Oct 2020; Revised: 25 Dec 2020; Accepted: 23 Dec 2020; Available online: 31 Dec 2020; Published: 31 Dec 2020.
Open Access Copyright (c) 2020 Journal of Biomedicine and Translational Research

Citation Format:
Abstract

Background: The sex determination process requires distinct signaling pathways to generate either testis or ovaries from the same precursor structures, the primordial gonad. Deviations of this signaling mechanism may result in disorders/differences of sex development (DSD). The 46, XX testicular DSD is a rare genetic condition identified by a discrepancy between genetic and phenotypic sex caused sex reversal syndrome.

 Case Presentation: We describe the case of a 5 years-old 46, XX boy with ambiguous genitalia. On physical examination he had severe hypospadias, bifid scrotum, micropenis and palpable bilateral testes. Cytogenetic analysis of patient reveals a 46, XX karyotype. Hormonal assay showed low level of FSH, LH and Testosterone and there was no evidence of Mullerian structures based on pelvic imaging. The histopathology of gonadal tissue showed a Leydig cell hyperplasia which gives the impression of Sertoli cell nodule. Polymerase chain reaction (PCR) analysis failed to identify the presence of SRY gene, therefore a diagnosis of 46, XX Testicular DSD with SRY-negative was established.

 Conclusion: This report presents a rare case of SRY-negative 46, XX Testicular DSD in a boy with ambiguous genitalia. A comprehensive management including clinical, cytogenetic and molecular analyses have indicated that undiscovered genetic or environmental factors needs to be elucidated. It is important to carry out further molecular testing to establish precise diagnosis of DSD and to provide appropriate genetic counseling for patients and their family.

Note: This article has supplementary file(s).

Fulltext View|Download |  common.other
Cover Letter
Subject
Type Other
  Download (49KB)    Indexing metadata
Keywords: Disorders of sex development; ambiguous genitalia,;46 XX,; SRY gene

Article Metrics:

Article Info
Section: Case Reports
Language : EN
Recent articles
The Effect of Glutathione on Serum Malondialdehyde (MDA) Level in Retinopathy of Prematurity Rat Models Peanut (Arachis hypogaea) Shells Extract and Apis dorsata Honey Reduce Matrix Metalloproteinase-3 in Monosodium Iodoacetate-Induced Osteoarthritic Rats Comparison of Very Low Birth Weight Preterm Infants with And Without Experienced Target Weight Gain on The Administration of Human Milk Fortifier Neuromyelitis Optica (NMO) in Children: A Rare Case Report SRY-negative in 46, XX Male Testicular DSD: a case report Radiotherapy for Recurrent Keloid: A Case Report Cyclic nucleotide in oocyte In vitro maturation in Assisted Reproductive Technology Hyperuricemia as a Risk Factor for Cardiovascular Diseases More recent articles
  1. Hughes IA, Houk CP, Ahmed SF. Consensus statement on management of intersex disorders. Archives of Disease in Childhood 2006;91:554-63
  2. Chapelle Adl, Hortling H, Niemi M, Wennstrom J. XX Sex Chromosomes in a Human Male. Acta Medica Scandinavia 1964:25-38
  3. Zenteno-Ruiz JC, Kofman-Alfaro S, Méndez JP. 46,XX Sex Reversal. Archives of Medical Research 2001;32:559-66
  4. Grinspon RP, Rey RA. Disorders of Sex Development with Testicular Differentiation in SRY-Negative 46,XX Individuals: Clinical and Genetic Aspects. Sex Dev 2016;10:1-11
  5. Vorona E, Zitzmann M, Gromoll J, Schuring AN, Nieschlag E. Clinical, endocrinological, and epigenetic features of the 46,XX male syndrome, compared with 47,XXY Klinefelter patients. J Clin Endocrinol Metab 2007;92:3458-65
  6. Ergun-Longmire B, Vinci G, Alonso L, Matthew S, Tansil S, Lin-Su K, et al. Clinical, Hormonal and Cytogenetic Evaluation of 46,XX Males and Review of the Literature. Journal of Pediatric Endocrinology & Metabolism 2005;18:739-48
  7. Knarston I, Ayers K, Sinclair A. Molecular mechanisms associated with 46,XX disorders of sex development. Clin Sci (Lond) 2016;130:421-32
  8. Kashimada K, Koopman P. Sry: the master switch in mammalian sex determination. Development 2010;137:3921-30
  9. Li T-F, Wu Q-Y, Zhang C, Li W-W, Zhou Q, Jiang W-J, et al. 46,XX testicular disorder of sexual development with SRY-negative caused by some unidentified mechanisms: a case report and review of the literature. BMC Urology 2014;14:2-8
  10. Iriarte BDA, Lopez N, Ramirez Y, Bastida N, Saez R, Bereciartua E, et al. A Rare Case of Sry-Negative 46, XX Testicular Disorder of Sex Development with Complete Masculinization: A Case Report and Literature Review. Journal of Clinical Case Reports 2020;10:1-3
  11. Cox JJ, Willatt L, Homfray T, Woods CG. A SOX9 Duplication and Familial 46,XX Developmental Testicular Disorder. N Engl J Med 2011;364:91-3
  12. Vetro A, Dehghani MR, Kraoua L, Giorda R, Beri S, Cardarelli L, et al. Testis development in the absence of SRY: chromosomal rearrangements at SOX9 and SOX3. Eur J Hum Genet 2015;23:1025-32
  13. Lee BY, Lee SY, Lee YW, Kim SY, Kim JW, Ryu HM, et al. Three cases of rare SRY-negative 46,XX testicular disorder of sexual development with complete masculinization and a review of the literature. Journal of Genetic Medicine 2016;13:78-88
  14. Bouty A, Ayers KL, Pask A, Heloury Y, Sinclair AH. The Genetic and Environmental Factors Underlying Hypospadias. Sex Dev 2015;9:239-59
  15. Giordano F, Abballe A, De Felip E, di Domenico A, Ferro F, Grammatico P, et al. Maternal exposures to endocrine disrupting chemicals and hypospadias in offspring. Birth Defects Res A Clin Mol Teratol 2010;88:241-50
  16. Ormond G, Nieuwenhuijsen MJ, Nelson P, Toledano MB, Iszatt N, Geneletti S, et al. Endocrine disruptors in the workplace, hair spray, folate supplementation, and risk of hypospadias: case-control study. Environ Health Perspect 2009;117:303-7
  17. Morera AM, Valmalle AF, Asensio MJ, Chossegros L, Chauvin MA, Durand P, et al. A study of risk factors for hypospadias in the Rhone-Alpes region (France). J Pediatr Urol 2006;2:169-77
  18. Hersmus R, van Bever Y, Wolffenbuttel KP, Biermann K, Cools M, Looijenga LH. The biology of germ cell tumors in disorders of sex development. Clin Genet 2017;91:292-301
  19. Dilworth JP, Farrow GM, Oesterling JE. Non-Germ Cell Tumors Of Testis. Urology 1991;37:399-417
  20. Kim JW, Bak CW, Chin MU, Cha DH, Yoon TK, Shim SH. SRY-negative 46,XX infertile male with Leydig cell hyperplasia: clinical, cytogenetic, and molecular analysis and review of the literature. Fertil Steril 2010;94:753 e5-9
  21. Naughton CK, Nadler RB, Basler JW, Humphrey PA. Leydig cell hyperplasia. British Journal of Urology 1998;81:282-9
  22. Mennie N, King SK, Marulaiah M, Ferguson P, Heloury Y, Kimber C. Leydig cell hyperplasia in children: Case series and review. J Pediatr Urol 2017;13:158-63
  23. Hisamatsu E, Takagi S, Nakagawa Y, Sugita Y, Yoshino K, Ueoka K, et al. Prepubertal testicular tumors: a 20-year experience with 40 cases. Int J Urol 2010;17:956-9
  24. Bangalore Krishna K, Houk CP, Lee PA. Pragmatic approach to intersex, including genital ambiguity, in the newborn. Semin Perinatol 2017;41:244-51
  25. Mieszczak J, Houk CP, Lee PA. Assignment of the sex of rearing in the neonate with a disorder of sex development. Curr Opin Pediatr 2009;21:541-7
  26. Ediati A, Juniarto AZ, Birnie E, Drop SL, Faradz SM, Dessens AB. Gender Development in Indonesian Children, Adolescents, and Adults with Disorders of Sex Development. Arch Sex Behav 2015;44:1339-61

Last update:

No citation recorded.

Last update:

No citation recorded.